Cynthia Smith

Cynthia Smith (board member) discloses dealings in 4 companies, chiefly Akebia Therapeutics, Inc., Agios Pharmaceuticals, Inc. and Spero Therapeutics, Inc. We count 22 filings; the first trade dates from 6 June 2019 and the latest from 18 June 2026.

Both buying and selling appear: 1 purchase worth €48k, against 1 sale worth €49k. Sales outweigh purchases by €1,226. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 12 share grants and 7 option exercises.

On 23 June 2026 came the latest disclosure, an option exercise in Agios Pharmaceuticals, Inc. The last purchase on record was published on 22 November 2019, which is 2,527 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.